Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
ExportLink to record
Permanent link

Direct link
BETA

Project

Project type/Form of grant
Project grant
Title [sv]
Antimikrobiella peptider framställda ur slaktbiprodukter som multifunktionella antibiotika.
Title [en]
Antimicrobial peptides from meat production waste as immune-boosting antibiotic agents.
Abstract [sv]
Antimikrobiella peptider utgör en del av immunförsvaret hos djur där de fyller många funktioner som till exempel bakteriedödande, sårläkande, immuncellsrekrytande och upprätthåller en hälsosam bakterieflora i tarmen. Typiskt för antimikrobiella peptider är att de dödar ett brett spektrum av sjukdomsalstrande organismer genom att förstöra deras membran. Preliminära studier visar att bindvävsprotein innehåller antimikrobiella peptider som frigörs vid infektioner när bindväven bryts ner av bakteriella enzymer. Detta projekt syftar till att utnyttja denna upptäckt genom att utveckla en enkel och miljövänlig framställningsprocess genom kontrollerad enzymatisk nedbrytning av djurvävnad, i första hand biprodukter vid grisslakt. Peptidextraktioner från processad vävnad kommer att testas för aktivitet mot bakterier och svamp. Den membranförstörande mekanismen detaljstuderas för att se hur och vilka membran som angrips och under vilka förutsättningar. Extraktens sammansättning kartläggs och deras eventuella toxicitet utvärderas. Effekt på sårläkning och immunsvar, samt deras förmåga att oskadligöra bakteriella toxiner, kommer därefter att studeras genom interdisciplinära samarbeten. Målet är praktisk produktion av terapeutiska och profylaktiska antibiotika för att stärka det naturliga immunsvaret vid infektioner i hud och slemhinnor. Extrakten har även en potentiell användning som hälsosamma ytkonserveringsmedel för foder och livsmedel.
Abstract [en]
Antimicrobial peptides are part of the innate immune system of animals where they serve multifunctional purposes including: broad-spectrum bactericidal activity, bacterial toxin inhibition, wound healing, immune cell recruiting and regulating the gut microbiota. These peptides are normally secreted by dedicated immune cells and act by disrupting the membranes of the pathogens. Preliminary data show that extracellular matrix proteins can harbor antimicrobial peptides that are released by protease degradation during bacterial infections. In this project, connective tissues from animal slaughterhouse byproducts will be prospected for antimicrobial peptides by controlled enzymatic digestion. Focus is put on cost-efficient and environmentally friendly processes of pig meat processing waste. The resulting peptide extracts will be screened for broad spectrum antibacterial and antifungal properties. In-depth mechanistic knowledge of extracts and individual peptides will be obtained by developed organism-specific membrane assays. The peptide compositions will be mapped and their toxicity assessed. Multifunctional properties in healing and immune response, as well as biofilm inhibition, will be assayed through interdisciplinary collaborations. The goal is to develop therapeutic and prophylactic antibiotics for boosting the natural immune response in infections of the skin and mucus membranes, as well as crude extracts for potential use as natural food and feed preservatives.
Publications (1 of 1) Show all publications
Jarmusch, S. A., Muhammad, T., Göransson, U. & Strömstedt, A. A. (2026). α-Helical Peptides Encoded in Collagen Exhibit Antimicrobial Activity with Low Cytotoxicity. Journal of Natural Products, 89(1), 242-250
Open this publication in new window or tab >>α-Helical Peptides Encoded in Collagen Exhibit Antimicrobial Activity with Low Cytotoxicity
2026 (English)In: Journal of Natural Products, ISSN 0163-3864, E-ISSN 1520-6025, Vol. 89, no 1, p. 242-250Article in journal (Refereed) Published
Abstract [en]

Endogenous antimicrobial peptides (AMPs) derived from host proteins represent a largely underexplored class of natural products tied to innate immunity. Here, we investigated collagen proteins as a source of latent alpha-helical AMPs encoded within nonfibrous extracellular matrix domains. Using a targeted in silico approach, verified collagen sequences were mined and prioritized based on secondary structure and three essential physicochemical properties: net charge, Boman index, and hydrophobic moment, yielding 107 predicted alpha-helical AMP candidates. The highest ranked peptides were synthesized and experimentally evaluated alongside benchmark AMPs and peptides prioritized by machine learning-based prediction tools. Three collagen-derived peptides identified by the targeted physicochemical approach exhibited broad-spectrum bioactivity against bacterial and fungal pathogens with minimum inhibitory concentrations comparable to those of LL-37 and melittin. In contrast, peptides ranked highly by machine learning predictors showed reduced or no activity. Collagen-derived peptides disrupted bacterial mimicking lipid membranes yet displayed markedly reduced cytotoxicity toward human cells, maintaining high viability at concentrations well above their antimicrobial MICs. These findings demonstrate that nonfibrous domains of extracellular matrix collagens constitute a previously underexplored reservoir of endogenous antimicrobial peptides with favorable biocompatibility, expanding the natural product space of host defense peptides and identifying collagen-derived AMPs as promising scaffolds for future antimicrobial discovery.

Place, publisher, year, edition, pages
American Chemical Society (ACS), 2026
National Category
Immunology in the Medical Area Molecular Biology Pharmaceutical Sciences
Identifiers
urn:nbn:se:uu:diva-582691 (URN)10.1021/acs.jnatprod.5c01318 (DOI)001661077800001 ()41528266 (PubMedID)2-s2.0-105028659693 (Scopus ID)
Funder
Swedish Research Council Formas, 2018-01616
Available from: 2026-03-20 Created: 2026-03-20 Last updated: 2026-03-20Bibliographically approved
Principal InvestigatorStrömstedt, Adam A.
Co-InvestigatorGöransson, Ulf
Coordinating organisation
Uppsala University
Funder
Period
2019-01-01 - 2021-12-31
National Category
ImmunologyPharmaceutical BiotechnologyMedicinal Chemistry
Identifiers
DiVA, id: project:6254Project, id: 2018-01616_Formas

Search in DiVA

ImmunologyPharmaceutical BiotechnologyMedicinal Chemistry

Search outside of DiVA

GoogleGoogle Scholar